- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Jubilant Pharmova Limited — Important, 09-12-2025: Updates
09-12-2025 | 06:50 pm
09-12-2025 | 06:50 pm
Jubilant Pharmova's Q2 consolidated revenue grew to ₹1,966.4 Cr, with net profit reaching ₹119.9 Cr. The company sold its API business to a subsidiary, reclassifying it as discontinued operations. This, along with tax adjustments, led to a standalone net loss of ₹6.4 Cr.
No comments yet. Be the first to comment!